What needs to be done to control the spread of Middle East respiratory syndrome coronavirus?
Identifieur interne : 001631 ( PubMed/Curation ); précédent : 001630; suivant : 001632What needs to be done to control the spread of Middle East respiratory syndrome coronavirus?
Auteurs : Michael Edelstein [Royaume-Uni] ; David L. Heymann [Royaume-Uni]Source :
- Future virology [ 1746-0794 ] ; 2015.
Abstract
Up to November 2014, Middle East respiratory syndrome coronavirus (MERS-CoV) has infected 935 individuals and killed 371, all originating in or with links to the Middle East. The mechanisms of transmission of the disease are not fully understood, but MERS-CoV seems to sustain itself in the human population through repeated re-introduction from a camel reservoir and is able to cause nosocomial outbreaks. The risk of a global spread of MERS-CoV is low. Epidemiological, serological and phylogenetic research, combined with one health surveillance, dynamic case definitions, active case finding, rigorous infection control, culturally sensitive risk communication and a continuous re-evaluation of new evidence will enable to better understand the disease, limit its spread and quantify its risk in order to better prepare for a hypothetical spread.
DOI: 10.2217/fvl.15.20
PubMed: 32201495
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001631
Links to Exploration step
pubmed:32201495Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">What needs to be done to control the spread of Middle East respiratory syndrome coronavirus?</title>
<author><name sortKey="Edelstein, Michael" sort="Edelstein, Michael" uniqKey="Edelstein M" first="Michael" last="Edelstein">Michael Edelstein</name>
<affiliation wicri:level="1"><nlm:affiliation>Center on Global Health Security, The Royal Institute of International Affairs, Chatham House, 10 St James's Square, London, SW1Y 4LE, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Center on Global Health Security, The Royal Institute of International Affairs, Chatham House, 10 St James's Square, London, SW1Y 4LE</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Heymann, David L" sort="Heymann, David L" uniqKey="Heymann D" first="David L" last="Heymann">David L. Heymann</name>
<affiliation wicri:level="1"><nlm:affiliation>Center on Global Health Security, The Royal Institute of International Affairs, Chatham House, 10 St James's Square, London, SW1Y 4LE, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Center on Global Health Security, The Royal Institute of International Affairs, Chatham House, 10 St James's Square, London, SW1Y 4LE</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:32201495</idno>
<idno type="pmid">32201495</idno>
<idno type="doi">10.2217/fvl.15.20</idno>
<idno type="wicri:Area/PubMed/Corpus">001631</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001631</idno>
<idno type="wicri:Area/PubMed/Curation">001631</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001631</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">What needs to be done to control the spread of Middle East respiratory syndrome coronavirus?</title>
<author><name sortKey="Edelstein, Michael" sort="Edelstein, Michael" uniqKey="Edelstein M" first="Michael" last="Edelstein">Michael Edelstein</name>
<affiliation wicri:level="1"><nlm:affiliation>Center on Global Health Security, The Royal Institute of International Affairs, Chatham House, 10 St James's Square, London, SW1Y 4LE, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Center on Global Health Security, The Royal Institute of International Affairs, Chatham House, 10 St James's Square, London, SW1Y 4LE</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Heymann, David L" sort="Heymann, David L" uniqKey="Heymann D" first="David L" last="Heymann">David L. Heymann</name>
<affiliation wicri:level="1"><nlm:affiliation>Center on Global Health Security, The Royal Institute of International Affairs, Chatham House, 10 St James's Square, London, SW1Y 4LE, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Center on Global Health Security, The Royal Institute of International Affairs, Chatham House, 10 St James's Square, London, SW1Y 4LE</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Future virology</title>
<idno type="ISSN">1746-0794</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Up to November 2014, Middle East respiratory syndrome coronavirus (MERS-CoV) has infected 935 individuals and killed 371, all originating in or with links to the Middle East. The mechanisms of transmission of the disease are not fully understood, but MERS-CoV seems to sustain itself in the human population through repeated re-introduction from a camel reservoir and is able to cause nosocomial outbreaks. The risk of a global spread of MERS-CoV is low. Epidemiological, serological and phylogenetic research, combined with one health surveillance, dynamic case definitions, active case finding, rigorous infection control, culturally sensitive risk communication and a continuous re-evaluation of new evidence will enable to better understand the disease, limit its spread and quantify its risk in order to better prepare for a hypothetical spread.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32201495</PMID>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1746-0794</ISSN>
<JournalIssue CitedMedium="Print"><Volume>10</Volume>
<Issue>5</Issue>
<PubDate><Year>2015</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Future virology</Title>
<ISOAbbreviation>Future Virol</ISOAbbreviation>
</Journal>
<ArticleTitle>What needs to be done to control the spread of Middle East respiratory syndrome coronavirus?</ArticleTitle>
<Pagination><MedlinePgn>497-505</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2217/fvl.15.20</ELocationID>
<Abstract><AbstractText>Up to November 2014, Middle East respiratory syndrome coronavirus (MERS-CoV) has infected 935 individuals and killed 371, all originating in or with links to the Middle East. The mechanisms of transmission of the disease are not fully understood, but MERS-CoV seems to sustain itself in the human population through repeated re-introduction from a camel reservoir and is able to cause nosocomial outbreaks. The risk of a global spread of MERS-CoV is low. Epidemiological, serological and phylogenetic research, combined with one health surveillance, dynamic case definitions, active case finding, rigorous infection control, culturally sensitive risk communication and a continuous re-evaluation of new evidence will enable to better understand the disease, limit its spread and quantify its risk in order to better prepare for a hypothetical spread.</AbstractText>
<CopyrightInformation>© 2015 Future Medicine Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Edelstein</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Center on Global Health Security, The Royal Institute of International Affairs, Chatham House, 10 St James's Square, London, SW1Y 4LE, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Heymann</LastName>
<ForeName>David L</ForeName>
<Initials>DL</Initials>
<AffiliationInfo><Affiliation>Center on Global Health Security, The Royal Institute of International Affairs, Chatham House, 10 St James's Square, London, SW1Y 4LE, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2015</Year>
<Month>05</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Future Virol</MedlineTA>
<NlmUniqueID>101278124</NlmUniqueID>
<ISSNLinking>1746-0794</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coronavirus</Keyword>
<Keyword MajorTopicYN="N">disease outbreak</Keyword>
<Keyword MajorTopicYN="N">emergency preparedness</Keyword>
<Keyword MajorTopicYN="N">surveillance</Keyword>
</KeywordList>
<CoiStatement>Financial & competing interests disclosure The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending or royalties. No writing assistance was utilized in the production of this manuscript.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>3</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>5</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>5</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32201495</ArticleId>
<ArticleId IdType="doi">10.2217/fvl.15.20</ArticleId>
<ArticleId IdType="pmc">PMC7080003</ArticleId>
</ArticleIdList>
<pmc-dir>pmcsd</pmc-dir>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2014 Jun;20(6):1049-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24856660</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Euro Surveill. 2013 Mar 14;18(11):20427</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23517868</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2013 Aug 24;382(9893):694-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23831141</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2014 Aug;20(8):1370-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25062254</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2013 Aug 1;369(5):466-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23902487</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>East Mediterr Health J. 2013;19 Suppl 1:S12-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23888790</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Trop Anim Health Prod. 2010 Aug;42(6):1087-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20195755</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>mBio. 2014 Feb 25;5(2):e00884-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24570370</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 Dec 18;349(25):2416-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14681507</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2014 Jun;20(6):1012-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24857749</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet Infect Dis. 2013 Oct;13(10):859-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23933067</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Curr Opin Pulm Med. 2014 May;20(3):233-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24626235</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):384-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15043017</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2014 Jul;20(7):1231-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24964193</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2013 Dec 14;382(9909):1993-2002</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24055451</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Euro Surveill. 2014 Jun 12;19(23):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24957745</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2014 Jul 15;59(2):160-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24723278</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>mBio. 2014 Feb 18;5(1):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24549846</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2014 Aug;20(8):1319-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25075637</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2012 Nov 8;367(19):1814-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23075143</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Pathol. 2015 Jan;235(2):175-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25294366</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2014 Oct;88(19):11297-303</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25031349</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2014 Jun 14;383(9934):2073-2082</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24857703</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2014 Sep;20(9):1527-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25148113</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>BMC Res Notes. 2014 Jun 11;7:358</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24920393</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>mBio. 2014 Apr 29;5(3):e01146-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24781747</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2014 Jan 15;209(2):243-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24218504</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Int J Infect Dis. 2013 Sep;17(9):e668-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23916548</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>mBio. 2014 Jul 22;5(4):e01450-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25053787</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2013 Aug 1;369(5):407-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23782161</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virulence. 2014 Aug 15;5(6):650-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25089913</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2014 Jun 26;370(26):2499-505</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24896817</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Expert Rev Clin Pharmacol. 2014 May;7(3):235-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24580083</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Euro Surveill. 2013 Jun 13;18(24):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23787161</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>PLoS Curr. 2013 Nov 12;5:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24270606</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Euro Surveill. 2013 Sep 05;18(36):pii=20574</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24079378</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2005 May 1;191(9):1472-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15809906</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001631 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001631 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:32201495 |texte= What needs to be done to control the spread of Middle East respiratory syndrome coronavirus? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:32201495" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |